John Freeman joined BeiGene in 2019 as Chief Safety Officer and Senior Vice President, Global Patient Safety. Prior to joining BeiGene, Mr. Freeman spent more than 30 years building high performing, global, innovative patient safety functions at GSK, Amgen, and Celgene. He additionally served on Celgene’s global operating and management committees.

Mr. Freeman holds a Qualifying Law Degree from the London College of Law, an M.Sc. in clinical research from the University of Wales, and a B.Sc. in pharmacology from the University of Leeds, U.K.